US Patent Issued to Athira Pharma on Sept. 23 for "Methods of treating neurodegenerative disease with substituted n-hexanoic-l-tyrosine-l-isoleucine-(6)-aminohexanoic amide analogues" (Washington Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,421,276, issued on Sept. 23, was assigned to Athira Pharma Inc. (Bothell, Wash.).

"Methods of treating neurodegenerative disease with substituted n-hexanoic-l-tyrosine-l-isoleucine-(6)-aminohexanoic amide analogues" was invented by Leen H. Kawas (Seattle), Jasbir Singh (Seattle), Lansing Joseph Stewart (Seattle) and William R. Baker (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present technology relates to compounds, kits, compositions, and methods useful for the treatment of numerous pathologies including dementia, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and other neurodegenerative diseases, spinal cord ...